Turn Therapeutics Inc. (TTRX)Healthcare | Biotechnology | Westlake Village, United States | NasdaqGM
9.84 USD
-0.27
(-2.671%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 9.84 |
Hot Take ↕ | Aug. 22, 2026, 3:15 a.m. EDT
The short-term outlook is cautiously optimistic due to a confluence of positive catalysts: a 'Strong Buy' upgrade from Ladenburg Thalmann, expanding clinical trial data for its dermatitis treatment, and a massive 370% premarket surge indicating intense institutional interest. Technically, the stock is trading well above its 50-day and 200-day averages, suggesting underlying momentum despite recent volatility. However, the long-term investment case remains neutral because the company lacks a multi-year price history to confirm sustained business quality improvements, and its fundamentals are precarious with negative earnings, negative return on equity, and a high debt-to-equity ratio typical of early-stage biotechs. There is no dividend income to consider. While the immediate catalysts suggest a potential rally, the lack of historical performance data prevents a confident long-term buy rating. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.113108 |
| AutoARIMA | 0.150434 |
| MSTL | 0.471023 |
| AutoETS | 0.498874 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 34% |
| H-stat | 0.70 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.219 |
| Excess Kurtosis | -0.96 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 891.126 |
| Market Cap | 298,818,208 |
| Forward P/E | -65.60 |
| Website | https://turntherapeutics.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 0.44428575 |
| Address1 | 250 N Westlake Blvd |
| Address2 | STE 210 |
| All Time High | 26.5 |
| All Time Low | 2.57 |
| Ask | 7.37 |
| Ask Size | 1 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 46,410 |
| Average Daily Volume3 Month | 80,964 |
| Average Volume | 80,964 |
| Average Volume10Days | 46,410 |
| Bid | 7.65 |
| Bid Size | 1 |
| Book Value | 0.023 |
| City | Westlake Village |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 9.84 |
| Current Ratio | 1.19 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 10.24 |
| Day Low | 9.47 |
| Debt To Equity | 891.126 |
| Display Name | Turn Therapeutics |
| Earnings Timestamp End | 1,794,513,600 |
| Earnings Timestamp Start | 1,794,513,600 |
| Ebitda | -8,506,469 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -33.968 |
| Enterprise Value | 288,946,848 |
| Eps Forward | -0.15 |
| Eps Trailing Twelve Months | -0.27 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 8.7244 |
| Fifty Day Average Change | 1.1156006 |
| Fifty Day Average Change Percent | 0.12787133 |
| Fifty Two Week Change Percent | 44.428574 |
| Fifty Two Week High | 26.5 |
| Fifty Two Week High Change | -16.66 |
| Fifty Two Week High Change Percent | -0.6286792 |
| Fifty Two Week Low | 2.57 |
| Fifty Two Week Low Change | 7.2700005 |
| Fifty Two Week Low Change Percent | 2.828794 |
| Fifty Two Week Range | 2.57 - 26.5 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,759,930,200,000 |
| Float Shares | 10,828,548 |
| Forward Eps | -0.15 |
| Forward P E | -65.6 |
| Free Cashflow | 4,167,285 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 2 |
| Fullday Change | -0.27 |
| Fullday Change Percent | -2.67062 |
| Fullday Price | 9.84 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Gross Profits | -1,613,342 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.53876 |
| Held Percent Institutions | 0.03865 |
| Implied Shares Outstanding | 30,367,704 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,025-10-08 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California. |
| Long Name | Turn Therapeutics Inc. |
| Market | us_market |
| Market Cap | 298,818,208 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_590974024 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -8,445,973 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 309,902,419 |
| Number Of Analyst Opinions | 1 |
| Open | 10.1 |
| Operating Cashflow | -4,321,048 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 818 546 4011 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 9.84 |
| Post Market Time | 1,787,947,805 |
| Previous Close | 10.11 |
| Price Hint | 2 |
| Price To Book | 427.82608 |
| Profit Margins | 0.0 |
| Quick Ratio | 1.174 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | -0.27 |
| Regular Market Change Percent | -2.67062 |
| Regular Market Day High | 10.24 |
| Regular Market Day Low | 9.47 |
| Regular Market Day Range | 9.47 - 10.24 |
| Regular Market Open | 10.1 |
| Regular Market Previous Close | 10.11 |
| Regular Market Price | 9.84 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 62,760 |
| Return On Assets | -0.50273 |
| Return On Equity | -6.86278 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 30,367,704 |
| Shares Percent Shares Out | 0.0038 |
| Shares Short | 84,329 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 57,729 |
| Short Name | Turn Therapeutics Inc. |
| Short Ratio | 1.47 |
| Source Interval | 15 |
| State | CA |
| Symbol | TTRX |
| Target High Price | 26.0 |
| Target Low Price | 26.0 |
| Target Mean Price | 26.0 |
| Target Median Price | 26.0 |
| Total Cash | 10,288,510 |
| Total Cash Per Share | 0.345 |
| Total Debt | 6,121,036 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.27 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 5.137575 |
| Two Hundred Day Average Change | 4.702425 |
| Two Hundred Day Average Change Percent | 0.9153005 |
| Type Disp | Equity |
| Volume | 62,760 |
| Website | https://turntherapeutics.com |
| Zip | 91,362 |